Trial intelligence / Profile preview

Oral minoxidil + spironolactone versus topical minoxidil for female pattern hair loss

RBR-6c26hxPhase 2Not yet recruiting

Sponsor
Universidade Estadual Paulista
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial in Female Pattern Hair Loss (FPHL) comparing Oral minoxidil + spironolactone with Topical minoxidil 5% (2 arms). Planned start Jan 2017; status: not yet recruiting.

02

Drugs

minoxidilspironolactone
03

Conditions

Female Pattern Hair Loss (FPHL)

Beyond the preview

Go deeper on RBR-6c26hx.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6c26hx.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call